March 7, 2023 – Rocket VR Well being (RVH), a digital actuality (VR) digital therapeutics firm remodeling psychological well being remedies with interactive mindfulness meditations and evidence-based digital therapeutics, has introduced that it has initiated a randomized management trial with Massachusetts Basic Hospital (MGH).
The 80-patient trial will look at the feasibility and preliminary efficacy of RVH’s VR digital therapeutic resolution in bettering high quality of life, symptom burden, psychological misery and self-efficacy in grownup sufferers with blood cancers admitted for hematopoietic stem cell transplantation (HCT) at MGH.
In keeping with RVH, sufferers present process such a remedy expertise immense bodily and psychological signs throughout a protracted four-week hospitalization and endure important short-term and long-term misery that impacts their high quality of life and their bodily and psychological well-being.
The great 4-week therapeutic intervention from RVH combines interactive therapeutic experiences, high-definition physician holograms (pictured above) and meditations that happen at nature-based places. Therapeutic content material is delivered on the Pico Neo 3 standalone VR headset, which is powered by Qualcomm’s XR2 processor and has over 2.5 hours of battery life. The headsets weigh just one.3 kilos and have an ergonomic design whereas leveraging gaze-based controls, eradicating the necessity for bodily controllers.
RVH said that digital well being interventions that assist sufferers in decreasing misery and bettering psychosocial well-being are missing. Consequently, the corporate partnered with MGH in early 2021 to co-develop a VR resolution. The therapeutic restoration program leverages classes discovered from evidence-based palliative care interventions for sufferers present process HCT that have been studied for years by the MGH group.
MGH is Harvard Medical Faculty’s largest instructing hospital. The Most cancers Outcomes Analysis and Schooling Program (CORE) at MGH conducts revolutionary analysis and academic packages to enhance the expertise and outcomes of sufferers and caregivers throughout the continuum of most cancers care.
“We’re happy to collaborate with Rocket VR Well being on this revolutionary undertaking that has the potential to vary the paradigm of supportive care supply for hospitalized sufferers with most cancers. The capability to make use of VR to enhance the bodily and psychological wellbeing of sufferers with most cancers enduring extended hospitalization can enhance entry and potential for scalability and dissemination of this supportive care platform,” commented Dr. Areej El-Jawahri, Affiliate Professor, Drugs, Harvard Medical Faculty and the Director of Digital Well being on the Mass Basic Most cancers Middle.
Additionally commenting on the collaboration was Rocket VR Well being co-founder and CEO, Sid Desai, who mentioned: “Up till now, VR expertise has been costly, cumbersome, and tough to make use of and operationalize inside a healthcare setting. Immediately, we are able to ship therapeutic VR interventions on light-weight, reasonably priced and ergonomic headsets with therapeutic experiences which can be extra partaking than what has been potential prior to now. This examine will information us in direction of validating the efficacy of our digital therapeutic in our effort to construct the go-to misery administration resolution for hospitalized sufferers.”
For extra info on Rocket VR Well being and its digital actuality digital therapeutic options for healthcare, please go to the corporate’s web site.
Picture credit score: Rocket VR Well being
Sam Sprigg
Sam is the Founder and Managing Editor of Auganix. With a background in analysis and report writing, he has been protecting XR trade information for the previous 5 years.
source https://vrgamenews.com/rocket-vr-health-collaborating-with-massachusetts-general-hospital-for-vr-trial/
No comments:
Post a Comment